ORGARAN

Brand name authorized in: Austria Canada Finland France Ireland Netherlands

Active ingredients

The drug ORGARAN contains one active pharmaceutical ingredient (API):

1 Danaparoid sodium
UNII 5004UU3156 - DANAPAROID SODIUM

Danaparoid sodium has been shown both in animal models and in human studies to be an effective antithrombotic substance. At therapeutic doses danaparoid sodium has no or only a minor effect on haemostatic plug formation, platelet function and platelet aggregability with no significant effect on bleeding time at the recommended doses.

Read about Danaparoid sodium

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Danaparoid
B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AB Heparin group
Discover more medicines within B01AB09

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
CA
Health Products and Food Branch
Identifier(s): 02129043
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 052951
FR
Base de données publique des médicaments
Identifier(s): 69449143
NL
Z-Index G-Standaard
Identifier(s): 13888285
NL
Z-Index G-Standaard, PRK
Identifier(s): 34339